Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products

Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products

US Patent 11040068 · Granted Jun 22, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and t2025
Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and t2025
Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and t2024
Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and t2024
Methods and compositions for treating retina-associated disease using CCR3-inhib2024
Methods and compositions for treating retina-associated disease using CCR3-inhib2023
Methods of treating a subject for pain2023
Treatment of aging-associated disease with modulators of leukotriene A4 hydrolas2022
Treatment of aging-associated disease with modulators of leukotriene A4 hydrolas2022
Dosing regimen for treatment of cognitive and motor impairments with blood plasm2022
Dosing regimen for treatment of cognitive and motor impairments with blood plasm2022
Dosing regimen for treatment of cognitive and motor impairments with blood plasm2022